EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

ESMO Rare Cancers

ISSN 3050-4619 · Elsevier BV

Latest articles

  1. Palliative systemic chemotherapy in peritoneal mesothelioma: a retrospective efficacy analysis of the RENAPE database

    J. Péron, B. You, L. Villeneuve, D. Goéré, I. Sourrouille, F. Dumont, M. Pocard, O. Sgarbura, C. Eveno, J.M. Bereder, L. Gladieff, B. Paquette, J.M. Guilloit, C. Brigand, C. Arvieux, J.J. Tuech, N. Benzerdjeb, C. Smolenschi, O. Glehen, V. Kepenekian, Julio Abba, Karine Abboud, Koceila Lamine Amroun, Julien Coget, Thomas Courvoisier, Marie Dazza, Gauthier Decanter, Cécile de Chaisemartin, Sylvaine Durand-Fontanier, Anne-Cécile Ezanno, Olivier Facy, Johann Gagnière, Laurent Ghouti, Frédéric Guyon, Bruno Heyd, Mehdi Karoui, Reza Kianmanesh, Jérémie H. Lefevre, Bernard Lelong, Brice Malgras

    Published: 2026-12DOI: 10.1016/j.esmorc.2026.100556

  2. One registry, many values: trade-offs in building a rare cancers data infrastructure

    C. Egher, S. van Hees, W. Boon, A. Trama, Jana Halamkova, Vit Novacek, Jean-Yves Blay, Alizée Diatchenko, Claire Chemin, Carlos Castresana, Kim Moon, Siri Larønningen, Andreas Muth, Marta Berndsen, Unai Zulaika Zurimendi, Franco Mercalli, Iwona Lugowska, Magdalena Rosinska, Aitor Almeida Escondrillas, Aritz Bilbao Jayo, Giuseppe Fico, Laura Lopez-Perez, Eugenio Gaeta, Itziar Alonso, Alejandro Alonso, Giorgio Cangioli, Catherine Chronaki, Roberta Gazzarata, Sébastien Ziegler, Vasiliki Tsiompanidou, Vincenzo Falanga, Federica Saccà, Daniele Pavia, Elena Mancuso, Barbara Sanavio, Ioanna Drympeta, Athanasios Patenidis, Konstantinos Votis, Alberto Lavelli, Soumitra Ghosh

    Published: 2026-06DOI: 10.1016/j.esmorc.2026.100520

Volumes

2026 · 3142025 · 103

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.